AIM
MDGL icon

Assured Investment Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Assured Investment Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-799
Closed -$93K – 1260
2018
Q1 		$93K Buy
+799
New +$98.6K ﹤0.01% 1058

Other funds holding MDGL

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Assured Investment Management's MDGL Position: Q2 2018 in Review

Assured Investment Management sold out of Madrigal Pharmaceuticals (MDGL) in Q2 2018, closing a stake of 799 shares — an estimated $93K sold.

Assured Investment Management first reported a position in MDGL in Q1 2018 and held it in 1 quarter. The position peaked at $93K in Q1 2018. 148 funds tracked by Wall St. Rank hold MDGL as of Q2 2018.

  • Assured Investment Management reported no remaining Madrigal Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • Assured Investment Management sold 799 Madrigal Pharmaceuticals shares in Q2 2018, an estimated $93K.
  • Assured Investment Management first reported a position in Madrigal Pharmaceuticals in Q1 2018 and held it in 1 quarter.
  • Assured Investment Management's Madrigal Pharmaceuticals position peaked at $93K in Q1 2018.
  • 148 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2018.

Based on Assured Investment Management's 13F filing for Q2 2018, filed 13 Aug 2018.